David Matuskey

A genetic method specifically delineates Th1-type Treg cells and their roles in tumor immunity

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

Depression

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

Major depressive disorder

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ

Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications

The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?

Interactions between the microbiota, immune and nervous systems in health and disease

Chronic inflammation in the etiology of disease across the life span

Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines

Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?

Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue

Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

The role of short-chain fatty acids in microbiota–gut–brain communication

A Binary Cre Transgenic Approach Dissects Microglia and CNS Border-Associated Macrophages

The neural basis of psychedelic action

The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Neurobiology of addiction: a neurocircuitry analysis

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Psychedelics and Other Psychoplastogens for Treating Mental Illness

The role of inflammation in depression: from evolutionary imperative to modern treatment target

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

Clinical neuropsychiatric considerations regarding nonsubstance or behavioral addictions

The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression

Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder

Lower synaptic density is associated with depression severity and network alterations

A single-day paradigm of self-regulated human cocaine administration

Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO

Regional and source-based patterns of [ 11 C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D 2 and D 3 receptor availability in cocaine-use disorder

Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study

Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients

Imaging synaptic density in the living human brain

Imaging robust microglial activation after lipopolysaccharide administration in humans with PET